Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial - Concepedia

Concepedia

Publication | Closed Access

Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial

29

Citations

24

References

2024

Year

Rabi Tawil, Kathryn R. Wagner, Johanna Hamel, Doris G. Leung, Jeffrey Statland, Leo H. Wang, Angela Genge, Sabrina Sacconi, Hanns Lochmüller, David Reyes‐Leiva,

The Lancet Neurology

Facioscapulohumeral Muscular DystrophyPlacebo-controlled Phase 2BRehabilitationMedicineNeuromusculoskeletal Disorder

References

	Year	Citations

Page 1